CanaFarma Hemp Products Corp. (CSE: CNFA) (the 'Corporation' or 'CanaFarma') is pleased to announce that its research and development division has begun developing its newest hemp-oil infused product line for skincare.

The first product in this new line is a hemp oil infused cream designed to help combat skin conditions related specifically to Acne.

Acne Vulgaris is a skin disease afflicting 79% to 95% of the adolescent population. In men and women older than 25 years, 40% to 54% have some degree of facial acne, and clinical facial acne persists into middle age in 12% of women and 3% of men(1). The psychological issues arising from Acne are serious and often damaging. CanaFarma has been developing this formulation together with Carl Germano, CNS, CDN, who is an authority in the cannabinoid and nutritional industry. The cream is designed to provide relief support to sufferers from Acne utilizing the most advanced actives and botanicals. Mr. Germano is a NY boardcertified clinical nutritionist and expert in cannabinoid product development, and Vice-President of Verdant Oasis, a leading grower, extractor and supplier of cannabinoid rich-hemp oil.

CanaFarma will be announcing the official delivery date of its product expected by end of Q2'20 and looks forward to introducing this new offering for people who are suffering from acne related problems. David Lonsdale, CEO of CanaFarma said, 'Medical Science is only just beginning to understand the benefits of Hemp Oil and the cannabinoids that it contains. CanaFarma is committed to delivering quality science-based products targeted towards specific benefits to the consumer. I am delighted to be announcing our Acne Cream and look forward to it being available to our customers.'

About CanaFarma Hemp Products Corp.

CanaFarma Hemp Products Corp. is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a well-established direct-to-consumer marketing approach.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain 'forward-looking statements' under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forwardlooking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Tel: (214) 704-7942

Email: david@canafarmacorp.com

(C) 2020 Electronic News Publishing, source ENP Newswire